All tenders
75N93023C00025
BAA RESEARCH AREA 004: DEVELOPMENT OF IN VITRO DIAGNOSTICS FOR BIODEFENSE, ANTIMICROBIAL RESISTANT INFECTIONS (AMR), AND EMERGING INFECTIOUS DISEASES.
National Institutes of Health · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedHealthcare & MedicalFederal
Basic information
- Reference number
- 75N93023C00025
- Issuing organization
- National Institutes of Health · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- BAA RESEARCH AREA 004: DEVELOPMENT OF IN VITRO DIAGNOSTICS FOR BIODEFENSE, ANTIMICROBIAL RESISTANT INFECTIONS (AMR), AND EMERGING INFECTIOUS DISEASES.
- Source
- USASpending (Federal)
- Source ID
- usa-75N93023C00025
Details
- Location
- United States
Description
BAA RESEARCH AREA 004: DEVELOPMENT OF IN VITRO DIAGNOSTICS FOR BIODEFENSE, ANTIMICROBIAL RESISTANT INFECTIONS (AMR), AND EMERGING INFECTIOUS DISEASES. Awarded to: SIEMENS HEALTHCARE DIAGNOSTICS INC. Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2023/07/24 12:00:00 AM UTC
- Closing date
- 2026/12/31 12:00:00 AM UTC
Estimated value
$5.4M USD
Classification
Normalized category
Healthcare & Medical